Applied Nutrition Plc (APN)
London Exchange · UK · prices in GBX · close of 19 Oct 2026
Key indicators
| Last close | GBX 290.50 |
|---|---|
| 52-week range | 162.00 – 356.00 |
| Return, 1 month / 3 months | +7.2% / −12.1% |
| Return, 1 year / 3 years | +61.4% / – |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 57 |
| Volatility (1 year) | 34.2% |
| Worst drawdown (1 year) | -24.5% |
| Average daily value traded | 238.75M GBX |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Applied Nutrition is a British sports nutrition company based in Liverpool. It develops and supplies supplements and functional food products, including protein powders, protein bars and energy drinks, marketed under its own brand. Its customers are mainly gym users, athletes and general consumers of fitness nutrition, and its products reach them through specialist retailers, gyms and online channels. The business covers product development, formulation and branding of sports and active lifestyle nutrition.
On this site Applied Nutrition Plc appears as a stock on the London Exchange (UK), code APN, with prices in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Applied Nutrition Plc (APN) trades on the London Exchange in UK. It last closed at GBX 290.50 on 19 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 629 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 61.4% and over the last three months it fell 12.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 68 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 8.7% | ||
| From 52-week high | -17.1% | ||
| Momentum | 67 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -12.1% | ||
| 6-month return | 31.7% | ||
| 12-month return, skipping the last month | 50.6% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.5% | ||
| Liquidity | 93 · Strong | Trades actively. | |
| Average daily value traded | 238.75M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +3.2% |
|---|---|
| 1 month | +7.2% |
| 3 months | −12.1% |
| 6 months | +31.7% |
| 1 year | +61.4% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 296.50 / 267.23 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 11.07 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.